Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM models.
Sign Up to like & getrecommendations! Published in 2022 at "Molecular carcinogenesis"
DOI: 10.1002/mc.23413
Abstract: In the present study, we performed a comparative stage-specific pathological and molecular marker evaluation of TMPRSS2-ERG fusion and PTEN loss-driven (TMPRSS2-ERG. Ptenflox/flox ) versus non-fusion-driven prostate tumorigenesis (Hi-Myc) in mice. Anterior, ventral, and dorsolateral prostates… read more here.
Keywords: fusion driven; fusion; erg fusion; stage ... See more keywords